Can misfolded proteins be beneficial? The HAMLET case

References

• Anfinsen CB. Principles that govern the folding of protein chains. Science. 1973; 181: 223–30
   PubMed Web of Science ®Google Scholar
• Cabrita LD, Bottomley SP. How do proteins avoid becoming too stable? Biophysical studies into metastable proteins. Eur Biophys J. 2004; 33: 83–8
   Google Scholar
• Bemporad F, Gsponer J, Hopearuoho HI, Plakoutsi G, Stati G, Stefani M, et al. Biological function in a non-native partially folded state of a protein. EMBO J. 2008; 27: 1525–35
   Google Scholar
• Svensson M, Hakansson A, Mossberg AK, Linse S, Svanborg C. Conversion of α-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci U S A. 2000; 97: 4221–6
   PubMed Web of Science ®Google Scholar
• Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS Biol. 2006; 4: e6
   PubMed Web of Science ®Google Scholar
• Shorter J, Lindquist S. Prions as adaptive conduits of memory and inheritance. Nat Rev Genet. 2005; 6: 435–50
   PubMed Web of Science ®Google Scholar
• Beadle GW, Tatum EL. Genetic control of biochemical reactions in neurospora. Proc Natl Acad Sci U S A. 1941; 27: 499–506
   PubMedGoogle Scholar
• Green ED, Chakravarti A. The human genome sequence expedition: views from the ‘base camp’. Genome Res. 2001; 11: 645–51
   Google Scholar
• Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001; 291: 1304–51
   PubMed Web of Science ®Google Scholar
• International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931–45.
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999; 24: 329–32
   PubMed Web of Science ®Google Scholar
• Claverie JM. Gene number. What if there are only 30,000 human genes?. Science. 2001; 291: 1255–7
   PubMed Web of Science ®Google Scholar
• Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000; 406: 959–64
   PubMed Web of Science ®Google Scholar
• Hakansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C. Apoptosis induced by a human milk protein. Proc Natl Acad Sci U S A. 1995; 92: 8064–8
   PubMed Web of Science ®Google Scholar
• Jeffery CJ. Moonlighting proteins. Trends Biochem Sci. 1999; 24: 8–11
   PubMed Web of Science ®Google Scholar
• Tompa P, Szasz C, Buday L. Structural disorder throws new light on moonlighting. Trends Biochem Sci. 2005; 30: 484–9
   PubMed Web of Science ®Google Scholar
• Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002; 295: 1852–8
   PubMed Web of Science ®Google Scholar
• Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell. 2006; 125: 443–51
   PubMed Web of Science ®Google Scholar
• Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992; 355: 33–45
   PubMed Web of Science ®Google Scholar
• Mok KH, Hore PJ. Photo-CIDNP NMR methods for studying protein folding. Methods. 2004; 34: 75–87
   PubMed Web of Science ®Google Scholar
• Dobson CM. The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci. 2001; 356: 133–45
   PubMed Web of Science ®Google Scholar
• Vendruscolo M, Paci E, Karplus M, Dobson CM. Structures and relative free energies of partially folded states of proteins. Proc Natl Acad Sci U S A. 2003; 100: 14817–21
   Google Scholar
• Levinthal C. Are there pathways for protein folding?. J Chim Phys. 1968; 65: 44–5
   Web of Science ®Google Scholar
• Dill KA, Chan HS. From Levinthal to pathways to funnels. Nat Struct Biol. 1997; 4: 10–9
   PubMedGoogle Scholar
• Baldwin RL. The nature of protein folding pathways: the classical versus the new view. J Biomol NMR. 1995; 5: 103–9
   PubMed Web of Science ®Google Scholar
• Bryngelson JD, Onuchic JN, Socci ND, Wolynes PG. Funnels, pathways, and the energy landscape of protein folding: a synthesis. Proteins. 1995; 21: 167–95
   PubMed Web of Science ®Google Scholar
• Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 2001; 498: 204–7
   PubMed Web of Science ®Google Scholar
• Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, Liu CY, et al. The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol. 2002; 3: 411–21
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006; 75: 333–66
   PubMed Web of Science ®Google Scholar
• Trzesniewska K, Brzyska M, Elbaum D. Neurodegenerative aspects of protein aggregation. Acta Neurobiol Exp (Wars) 2004; 64: 41–52
   Google Scholar
• Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988; 85: 7341–5
   PubMedGoogle Scholar
• Soto C, Castano EM, Frangione B, Inestrosa NC. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid ß-peptide modulates amyloid formation. J Biol Chem. 1995; 270: 3063–7
   PubMed Web of Science ®Google Scholar
• Barrow CJ, Yasuda A, Kenny PT, Zagorski MG. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol. 1992; 225: 1075–93
   PubMed Web of Science ®Google Scholar
• Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J Mol Biol. 1992; 228: 460–73
   PubMed Web of Science ®Google Scholar
• Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med. 1998; 4: 827–31
   PubMed Web of Science ®Google Scholar
• Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM, Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med. 1998; 4: 822–6
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS. Prions and their partners in crime. Nature. 2006; 443: 803–10
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell. 1998 1; 93:337–48.
   Google Scholar
• Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. Conversion of a-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993; 90: 10962–6
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol. 2006; 4: 765–75
   PubMed Web of Science ®Google Scholar
• Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell. 2005; 121: 195–206
   PubMed Web of Science ®Google Scholar
• Si K, Lindquist S, Kandel ER. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell. 2003; 115: 879–91
   PubMed Web of Science ®Google Scholar
• Lindquist S, Krobitsch S, Li L, Sondheimer N. Investigating protein conformation-based inheritance and disease in yeast. Philos Trans R Soc Lond B Biol Sci. 2001; 356: 169–76
   Google Scholar
• Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 1996; 15: 3127–34
   PubMed Web of Science ®Google Scholar
• Svensson M, Sabharwal H, Hakansson A, Mossberg AK, Lipniunas P, Leffler H, et al. Molecular characterization of alpha-lactalbumin folding variants that induce apoptosis in tumor cells. J Biol Chem. 1999; 274: 6388–96
   PubMed Web of Science ®Google Scholar
• Arai M, Kuwajima K. Role of the molten globule state in protein folding. Adv Protein Chem. 2000; 53: 209–82
   PubMedGoogle Scholar
• Ptitsyn OB. Molten globule and protein folding. Adv Protein Chem. 1995; 47: 83–229
   PubMedGoogle Scholar
• Halliburton WD. The proteids of milk. J Physiol. 1890; 11: 448–63
   Google Scholar
• Heine WE, Klein PD, Reeds PJ. The importance of α-lactalbumin in infant nutrition. J Nutr. 1991; 121: 277–83
   PubMed Web of Science ®Google Scholar
• Lonnerdal B, Forsum E. Casein content of human milk. Am J Clin Nutr. 1985; 41: 113–20
   PubMed Web of Science ®Google Scholar
• Zweig G, Block RJ. Studies on bovine whey proteins. III. The preparation of crystalline a-lactalbumin and ß-lactoglobulin ferrilactin. Arch Biochem Biophys. 1954; 51: 200–7
   PubMedGoogle Scholar
• Acharya KR, Ren JS, Stuart DI, Phillips DC, Fenna RE. Crystal structure of human α-lactalbumin at 1.7 A resolution. J Mol Biol. 1991; 221: 571–81
   PubMedGoogle Scholar
• Chandra N, Brew K, Acharya KR. Structural evidence for the presence of a secondary calcium binding site in human α-lactalbumin. Biochemistry. 1998; 37: 4767–72
   Google Scholar
• Fenna RE. Crystallization of human α-lactalbumin. J Mol Biol. 1982; 161: 211–5
   PubMedGoogle Scholar
• Vanaman TC, Brew K, Hill RL. The disulfide bonds of bovine a-lactalbumin. J Biol Chem. 1970; 245: 4583–90
   PubMed Web of Science ®Google Scholar
• Hiraoka Y, Segawa T, Kuwajima K, Sugai S, Murai N. α-Lactalbumin: a calcium metalloprotein. Biochem Biophys Res Commun. 1980; 95: 1098–104
   PubMed Web of Science ®Google Scholar
• Kuwajima K. The molten globule state of α-lactalbumin. FASEB J. 1996; 10: 102–9
   PubMed Web of Science ®Google Scholar
• Mok KH, Nagashima T, Day IJ, Hore PJ, Dobson CM. Multiple subsets of side-chain packing in partially folded states of α-lactalbumins. Proc Natl Acad Sci U S A. 2005; 102: 8899–904
   PubMed Web of Science ®Google Scholar
• Peng ZY, Kim PS. A protein dissection study of a molten globule. Biochemistry. 1994; 33: 2136–41
   Google Scholar
• Schulman BA, Redfield C, Peng ZY, Dobson CM, Kim PS. Different subdomains are most protected from hydrogen exchange in the molten globule and native states of human α-lactalbumin. J Mol Biol. 1995; 253: 651–7
   PubMed Web of Science ®Google Scholar
• Chyan CL, Wormald C, Dobson CM, Evans PA, Baum J. Structure and stability of the molten globule state of guinea-pig α-lactalbumin: a hydrogen exchange study. Biochemistry. 1993; 32: 5681–91
   PubMed Web of Science ®Google Scholar
• Polverino de Laureto P, Frare E, Gottardo R, Fontana A. Molten globule of bovine α-lactalbumin at neutral pH induced by heat, trifluoroethanol, and oleic acid: a comparative analysis by circular dichroism spectroscopy and limited proteolysis. Proteins. 2002; 49: 385–97
   PubMed Web of Science ®Google Scholar
• Wu LC, Peng ZY, Kim PS. Bipartite structure of the α-lactalbumin molten globule. Nat Struct Biol. 1995; 2: 281–6
   PubMedGoogle Scholar
• Wu LC, Kim PS. A specific hydrophobic core in the α-lactalbumin molten globule. J Mol Biol. 1998; 280: 175–82
   Google Scholar
• Pettersson J, Mossberg AK, Svanborg C. α-Lactalbumin species variation, HAMLET formation, and tumor cell death. Biochem Biophys Res Commun. 2006; 345: 260–70
   PubMed Web of Science ®Google Scholar
• Chedad A, Van Dael H. Kinetics of folding and unfolding of goat α-lactalbumin. Proteins. 2004; 57: 345–56
   Google Scholar
• Dolgikh DA, Gilmanshin RI, Brazhnikov EV, Bychkova VE, Semisotnov GV, Venyaminov S, et al. α-Lactalbumin: compact state with fluctuating tertiary structure?. FEBS Lett. 1981; 136: 311–5
   PubMed Web of Science ®Google Scholar
• Peng ZY, Wu LC, Schulman BA, Kim PS. Does the molten globule have a native-like tertiary fold?. Philos Trans R Soc Lond B Biol Sci. 1995; 348: 43–7
   Google Scholar
• Permyakov SE, Uversky VN, Veprintsev DB, Cherskaya AM, Brooks CL, Permyakov EA, et al. Mutating aspartate in the calcium-binding site of α-lactalbumin: effects on the protein stability and cation binding. Protein Eng. 2001; 14: 785–9
   PubMedGoogle Scholar
• Svensson M, Fast J, Mossberg AK, Duringer C, Gustafsson L, Hallgren O, et al. α-Lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human α-lactalbumin made lethal to tumor cells). Protein Sci. 2003; 12: 2794–804
   PubMed Web of Science ®Google Scholar
• Wu LC, Schulman BA, Peng ZY, Kim PS. Disulfide determinants of calcium-induced packing in α-lactalbumin. Biochemistry. 1996; 35: 859–63
   Google Scholar
• Jensen RG. The lipids in human milk. Prog Lipid Res. 1996; 35: 53–92
   PubMed Web of Science ®Google Scholar
• Svensson M, Mossberg AK, Pettersson J, Linse S, Svanborg C. Lipids as cofactors in protein folding: Stereo-specific lipid-protein interactions are required to form HAMLET (human α-lactalbumin made lethal to tumor cells). Protein Sci. 2003; 12: 2805–14
   PubMed Web of Science ®Google Scholar
• Polverino de Laureto P, Scaramella E, Frigo M, Wondrich FG, De Filippis V, Zambonin M, et al. Limited proteolysis of bovine α-lactalbumin: isolation and characterization of protein domains. Protein Sci. 1999; 8: 2290–303
   Google Scholar
• Svanborg C, Agerstam H, Aronson A, Bjerkvig R, Duringer C, Fischer W, et al. HAMLET kills tumor cells by an apoptosis-like mechanism–cellular, molecular, and therapeutic aspects. Adv Cancer Res. 2003; 88: 1–29
   PubMed Web of Science ®Google Scholar
• Kohler C, Gogvadze V, Hakansson A, Svanborg C, Orrenius S, Zhivotovsky B. A folding variant of human α-lactalbumin induces mitochondrial permeability transition in isolated mitochondria. Eur J Biochem. 2001; 268: 186–91
   Google Scholar
• Kohler C, Hakansson A, Svanborg C, Orrenius S, Zhivotovsky B. Protease activation in apoptosis induced by MAL. Exp Cell Res. 1999; 249: 260–8
   Google Scholar
• Hallgren O, Gustafsson L, Irjala H, Selivanova G, Orrenius S, Svanborg C. HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53. Apoptosis. 2006; 11: 221–33
   Google Scholar
• Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12 Suppl 2005; 2: 1509–18
   Google Scholar
• Baehrecke EH. Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol. 2005; 6: 505–10
   PubMed Web of Science ®Google Scholar
• Debnath J, Baehrecke EH, Kroemer G. Does autophagy contribute to cell death?. Autophagy. 2005; 1: 66–74
   PubMed Web of Science ®Google Scholar
• Duringer C, Hamiche A, Gustafsson L, Kimura H, Svanborg C. HAMLET interacts with histones and chromatin in tumor cell nuclei. J Biol Chem. 2003; 278: 42131–5
   PubMed Web of Science ®Google Scholar
• Fischer W, Gustafsson L, Mossberg AK, Gronli J, Mork S, Bjerkvig R, et al. Human α-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res. 2004; 64: 2105–12
   PubMed Web of Science ®Google Scholar
• Hakansson A, Andreasson J, Zhivotovsky B, Karpman D, Orrenius S, Svanborg C. Multimeric α-lactalbumin from human milk induces apoptosis through a direct effect on cell nuclei. Exp Cell Res. 1999; 246: 451–60
   PubMedGoogle Scholar
• Wenzel T, Baumeister W. Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol. 1995; 2: 199–204
   PubMedGoogle Scholar
• Brest P, Gustafsson M, Mossberg AK, Gustafsson L, Duringer C, Hamiche A, et al. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. Cancer Res. 2007; 67: 11327–34
   PubMedGoogle Scholar
• Gustafsson L, Leijonhufvud I, Aronsson A, Mossberg AK, Svanborg C. Treatment of skin papillomas with topical α-lactalbumin-oleic acid. N Engl J Med. 2004; 350: 2663–72
   PubMed Web of Science ®Google Scholar
• Mossberg AK, Wullt B, Gustafsson L, Mansson W, Ljunggren E, Svanborg C. Bladder cancers respond to intravesical instillation of HAMLET (human a-lactalbumin made lethal to tumor cells). Int J Cancer. 2007; 121: 1352–9
   PubMed Web of Science ®Google Scholar
• Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci U S A. 2005; 102: 315–20
   PubMed Web of Science ®Google Scholar
• Fernandez A, Berry RS. Proteins with H-bond packing defects are highly interactive with lipid bilayers: implications for amyloidogenesis. Proc Natl Acad Sci U S A. 2003; 100: 2391–6
   PubMed Web of Science ®Google Scholar
• Sparr E, Engel MF, Sakharov DV, Sprong M, Jacobs J, de Kruijff B, et al. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 2004; 577: 117–20
   PubMed Web of Science ®Google Scholar
• Zhao H, Jutila A, Nurminen T, Wickstrom SA, Keski-Oja J, Kinnunen PK. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Biochemistry. 2005; 44: 2857–63
   Google Scholar
• Zhao H, Tuominen EK, Kinnunen PK. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry. 2004; 43: 10302–7
   PubMedGoogle Scholar
• Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 1991; 51: 3062–6
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein folding and misfolding. Nature. 2003; 426: 884–90
   PubMed Web of Science ®Google Scholar
• Fasano C, Campana V, Zurzolo C. Prions: protein only or something more? Overview of potential prion cofactors. J Mol Neurosci. 2006; 29: 195–214
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature. 2005; 437: 257–61
   PubMed Web of Science ®Google Scholar
• Gharibyan AL, Zamotin V, Yanamandra K, Moskaleva OS, Margulis BA, Kostanyan IA, et al. Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J Mol Biol. 2007; 365: 1337–49
   PubMed Web of Science ®Google Scholar
• Goers J, Permyakov SE, Permyakov EA, Uversky VN, Fink AL. Conformational prerequisites for α-lactalbumin fibrillation. Biochemistry. 2002; 41: 12546–51
   PubMed Web of Science ®Google Scholar
• Yang F, Jr, Zhang M, Zhou BR, Chen J, Liang Y. Oleic acid inhibits amyloid formation of the intermediate of α-lactalbumin at moderately acidic pH. J Mol Biol. 2006; 362: 821–34
   PubMedGoogle Scholar
• Zhao H, Sood R, Jutila A, Bose S, Fimland G, Nissen-Meyer J, et al. Interaction of the antimicrobial peptide pheromone plantaricin A with model membranes: implications for a novel mechanism of action. Biochim Biophys Acta. 2006; 1758: 1461–74
   Google Scholar
• Hakansson A, Svensson M, Mossberg AK, Sabharwal H, Linse S, Lazou I, et al. A folding variant of α-lactalbumin with bactericidal activity against Streptococcus pneumoniae. Molecular microbiology. 2000; 35: 589–600
   PubMedGoogle Scholar
• Mok KH, Pettersson J, Orrenius S, Svanborg C. HAMLET, protein folding, and tumor cell death. Biochem Biophys Res Commun. 2007; 354: 1–7
   PubMed Web of Science ®Google Scholar
• Ren J, Stuart DI, Acharya KR. α-lactalbumin possesses a distinct zinc binding site. J Biol Chem. 1993; 268: 19292–8
   PubMedGoogle Scholar
• Thompson J, Winter N, Terwey D, Bratt J, Banaszak L. The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J Biol Chem. 1997; 272: 7140–50
   PubMed Web of Science ®Google Scholar
• Koradi R, Billeter M, Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph. 1996;14:51–5, 29–32.
   PubMedGoogle Scholar